MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PIRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pieris Pharmaceuticals (PIRS) Ownership - Who owns Pieris Pharmaceuticals?

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 246-8998
Employees
50
Web
https://www.pieris.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.96M
P/E Ratio
N/A
Total Cash
19.36M
Projected Growth
N/A
Total Debt
N/A
Revenue
1.35M
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash/Share
14.67
Total Debt/Equity
N/A
Revenue/Share
1.06 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PIRS
A.I. Advisor
published General Information

General Information

a developer of an anticalin-brand protein technology

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 246-8998
Employees
50
Web
https://www.pieris.com